Doris Renee Brown, MD, PhD
- Clinical Associate Professor, Radiation Oncology
Doris Renee Brown, MD, PhD
Research Interests
- Brachytherapy
- Breast Cancer
- Late Effects After Childhood Cancer Therapy
- Gynecological Malignancies
- Cancer Clinical Trials
- Late Effects of Cancer Therapy
- Education
- MD, Wake Forest University School of Medicine, 2006
- Residency
- Internal Medicine, University of Michigan Hospitals and Health Centers, 2007
- Radiation Oncology, University of Michigan Hospitals and Health Centers, 2011
- Board Certifications
- American Board of Radiology, Radiation Oncology
- Memberships
- American Society for Radiation Oncology
- Radiological Society of North America
- American Association of Women Radiologists
- American Society of Clinical Oncology
- Positions
- Clinical Associate Professor, Radiation Oncology
- Departments and Affiliations
- Radiation Oncology
- Comprehensive Cancer Center
Research
- Effect at One Year of Adjuvant Trastuzumab for HER2+ Breast Cancer Combined with Radiation or an Anthracycline on Left Ventricular Ejection Fraction. Andersen MM, Ayala-Peacock D, Bowers J, Kooken BW, D'Agostino RB, Jordan JH, Vasu S, Thomas A, Klepin HD, Brown DR, Hundley WG. Am J Cardiol. 2020 06; 125(12):1906-1912.
- Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial. Cramer CK, Alphonse-Sullivan N, Isom S, Metheny-Barlow LJ, Cummings TL, Page BR, Brown DR, Blackstock AW, Peiffer AM, Strowd RE, Rapp S, Lesser GJ, Shaw EG, Chan MD. J. Cancer Res. Clin. Oncol. 2019 Feb; 145(2):337-344.
- Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population. Hu JJ, Urbanic JJ, Case LD, Takita C, Wright JL, Brown DR, Langefeld CD, Lively MO, Mitchell SE, Thakrar A, Bryant D, Baglan K, Strasser J, Baez-Diaz L, Lesser GJ, Shaw EG. J. Clin. Oncol. 2018 08; 36(24):2473-2482.
- Potential prognostic markers for survival and neurologic death in patients with breast cancer brain metastases who receive upfront SRS alone. Shenker RF, Hughes RT, McTyre ER, Lanier C, Lo HW, Metheny-Barlow L, Su J, Thomas A, Brown DR, Avery T, Pasche B, Cramer CK, Laxton AW, Tatter SB, Watabe K, Chan MD. . 2018; 5(4):277-283.
- Intracystic papillary carcinoma of the breast: A SEER database analysis of implications for therapy. Mogal H, Brown DR, Isom S, Griffith K, Howard-McNatt M. Breast. 2016 Jun; 27:87-92.